Android Apple

ResMed Inc. (RMD) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$237.40

north_east $5.82 (2.51%)
Day's range
$231
Day's range
$238.53

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/12/2024 Stifel Nicolaus Jonathan Block $250.00 $242.51   3.09%
10/01/2024 RBC Capital Craig Wong-Pan $224.00 $238.95   -6.26%
09/23/2024 Robert W. Baird Joe Vruwink $280.00 $246.18   13.74%
09/17/2024 Wolfe Research Mike Polark $180.00 $250.88   -28.25%
04/10/2024 RBC Capital Craig Wong-Pan $187.00 $194.27   -3.74%
04/01/2024 Stifel Nicolaus Mike Matson $224.00 $198.03   13.11%
10/27/2023 Oppenheimer Suraj Kalia $175.00 $134.65   29.97%
09/06/2023 Needham Mike Matson $180.00 $153.89   16.97%
10/13/2021 Oppenheimer Suraj Kalia $312.00 $253.77   22.95%
08/03/2021 Morgan Stanley Sean Laaman $250.00 $271.87   -8.04%
07/27/2021 Jefferies Anthony Petrone $240.00 $264.75   -9.35%

ResMed Inc. FAQ's

What analysts cover ResMed Inc.?

ResMed Inc. has been rated by research analysts at Stifel Nicolaus, RBC Capital, Robert W. Baird, Wolfe Research, Oppenheimer, Needham in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.